Point72 Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-63,373
| Closed | -$5.7M | – | 4619 |
|
|
2025
Q4 | $5.7M | Buy |
+63,373
| New | +$6.01M | 0.01% | 1742 |
|
|
2025
Q2 | – | Sell |
-87,829
| Closed | -$9.94M | – | 2662 |
|
|
2025
Q1 | $9.94M | Buy |
+87,829
| New | +$9.4M | 0.02% | 689 |
|
|
2023
Q4 | – | Sell |
-890,377
| Closed | -$99.9M | – | 2939 |
|
|
2023
Q3 | $99.9M | Sell |
890,377
-744,884
| -46% | -$94.6M | 0.29% | 67 |
|
|
2023
Q2 | $238M | Buy |
1,635,261
+890,708
| +120% | +$121M | 0.71% | 11 |
|
|
2023
Q1 | $96.2M | Sell |
744,553
-393,500
| -35% | -$49.4M | 0.3% | 72 |
|
|
2022
Q4 | $145M | Sell |
1,138,053
-149,805
| -12% | -$17.4M | 0.49% | 31 |
|
|
2022
Q3 | $135M | Buy |
1,287,858
+755,858
| +142% | +$82.9M | 0.54% | 26 |
|
|
2022
Q2 | $55.9M | Buy |
532,000
+424,988
| +397% | +$50.4M | 0.24% | 107 |
|
|
2022
Q1 | $13.7M | Buy |
+107,012
| New | +$12.9M | 0.05% | 430 |
|
|
2021
Q4 | – | Sell |
-135,033
| Closed | -$19.2M | – | 1338 |
|
|
2021
Q3 | $19.2M | Buy |
+135,033
| New | +$19.9M | 0.08% | 319 |
|
|
2020
Q4 | – | Sell |
-389,939
| Closed | -$51.5M | – | 1171 |
|
|
2020
Q3 | $51.5M | Buy |
389,939
+108,181
| +38% | +$14.1M | 0.26% | 93 |
|
|
2020
Q2 | $32.7M | Buy |
281,758
+219,328
| +351% | +$25.3M | 0.21% | 133 |
|
|
2020
Q1 | $6.13M | Buy |
62,430
+39,361
| +171% | +$5.16M | 0.05% | 360 |
|
|
2019
Q4 | $3.35M | Buy |
+23,069
| New | +$3.18M | 0.02% | 553 |
|
|
2019
Q3 | – | Sell |
-937,438
| Closed | -$107M | – | 1516 |
|
|
2019
Q2 | $107M | Buy |
937,438
+589,022
| +169% | +$69M | 0.56% | 38 |
|
|
2019
Q1 | $43.2M | Buy |
348,416
+154,364
| +80% | +$17.5M | 0.2% | 131 |
|
|
2018
Q4 | $19.5M | Sell |
194,052
-429,954
| -69% | -$48.4M | 0.1% | 263 |
|
|
2018
Q3 | $79.6M | Buy |
+624,006
| New | +$74.2M | 0.33% | 79 |
|
|
2018
Q1 | – | Sell |
-528,067
| Closed | -$61.9M | – | 1159 |
|
|
2017
Q4 | $61.9M | Sell |
528,067
-190,770
| -27% | -$21.6M | 0.27% | 98 |
|
|
2017
Q3 | $81.7M | Buy |
718,837
+81,576
| +13% | +$9.42M | 0.36% | 60 |
|
|
2017
Q2 | $79.4M | Sell |
637,261
-447,844
| -41% | -$53.1M | 0.45% | 46 |
|
|
2017
Q1 | $129M | Buy |
1,085,105
+756,535
| +230% | +$85.7M | 0.72% | 20 |
|
|
2016
Q4 | $32.9M | Sell |
328,570
-173,285
| -35% | -$18.6M | 0.23% | 129 |
|
|
2016
Q3 | $63.4M | Buy |
501,855
+14,562
| +3% | +$1.8M | 0.45% | 42 |
|
|
2016
Q2 | $57M | Sell |
487,293
-63,345
| -12% | -$7.17M | 0.39% | 51 |
|
|
2016
Q1 | $57M | Buy |
550,638
+28,325
| +5% | +$2.74M | 0.44% | 45 |
|
|
2015
Q4 | $52M | Buy |
522,313
+477,096
| +1,055% | +$46.7M | 0.43% | 61 |
|
|
2015
Q3 | $4.12M | Buy |
+45,217
| New | +$4.53M | 0.03% | 451 |
|
|
2015
Q2 | – | Sell |
-285,207
| Closed | -$32.5M | – | 873 |
|
|
2015
Q1 | $32.5M | Buy |
285,207
+49,440
| +21% | +$5.64M | 0.22% | 135 |
|
|
2014
Q4 | $26M | Sell |
235,767
-33,887
| -13% | -$3.57M | 0.18% | 177 |
|
|
2014
Q3 | $26.3M | Sell |
269,654
-120,416
| -31% | -$11.8M | 0.2% | 142 |
|
|
2014
Q2 | $39.3M | Buy |
+390,070
| New | +$38.1M | 0.25% | 113 |
|
Other funds holding ZBH
VCM
VPM
Point72 Asset Management's ZBH Position: Q1 2026 in Review
Point72 Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 63,373 shares — an estimated $5.7M sold.
Point72 Asset Management first reported a position in ZBH in Q2 2014 and held it in 32 quarters. The position peaked at $238M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Point72 Asset Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Point72 Asset Management sold 63,373 Zimmer Biomet shares in Q1 2026, an estimated $5.7M.
- Point72 Asset Management first reported a position in Zimmer Biomet in Q2 2014 and held it in 32 quarters.
- Point72 Asset Management's Zimmer Biomet position peaked at $238M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.